Direct tumor injections aim to boost chemo power against stomach cancer
NCT ID NCT07059611
Summary
This study is testing whether injecting an experimental treatment called RP2 directly into stomach or esophagus tumors, along with standard chemotherapy (FLOT), is safe and works better than chemotherapy alone before surgery. Researchers want to see if this combination kills more cancer cells completely before the tumor is removed. The study will enroll 34 patients with stage II or higher stomach or esophagus cancer that hasn't spread to other organs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Abramson Cancer Center at the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.